期刊文献+

泛素蛋白连接酶复合体KPC的研究进展 被引量:1

Research Progress of Ubiquitin Ligase Complex KPC
下载PDF
导出
摘要 泛素蛋白酶体途径是真核生物体内最重要的蛋白质降解途径之一,其中,目标蛋白的泛素化过程涉及泛素激活酶、泛素结合酶和泛素蛋白连接酶(E3)。目标蛋白识别中起关键作用的是E3,Kip1泛素-促进复合体(KPC)是一种E3复合体,由KPC1和KPC2组成,KPC1在C端含有一个环指结构域作为催化亚基,是E3不可缺少的组成部分,KPC2含有一个类泛素结构域和两个泛素相关结构域。KPC广泛存在于真核生物中,在神经系统疾病、血液系统疾病、肿瘤疾病等方面起着重要的调控作用。 Ubiquitin-proteasome pathway is one of the most important protein degradation pathways in eukaryotes,among which ubiquitinatioa of target proteins involves in the ubiquitin-activating enzyme, the ubiquitin-eonjugating enzyme and the ubiquitin ligase (E3). The ubiquitin ligase plays a key role in the identification of target proteins, Kip1 ubiquitination-promoting complex(KPC) being a ubiquitin ligase com- plex that consists of KPC1 and KPC2. KPC1 contains a RING finger domain at the C-terminus as the catalytic subunit that is the integral part of the ubiquitin ligase E3, and KPC2 contains a ubiquitin-like domain and two ubiquitin-assoeiated domains. KPC is widespread in the eukaryotes, playing an important role of regula- tion in nervous system diseases, blood diseases and neoplastic diseases.
出处 《医学综述》 2016年第21期4161-4165,共5页 Medical Recapitulate
基金 国家自然科学基金(81270221)
关键词 泛素蛋白酶体途径 泛素蛋白连接酶 胞质泛素蛋白连接酶1 胞质泛素蛋白连接酶2 Ubiquitin-proteasome pathway Ubiquitin ligase Kip1 ubiquitylation-promoting complex 1 Kipl ubiquitylation-promoting complex 2
  • 相关文献

参考文献7

二级参考文献109

  • 1初同伟,焦文仓,周跃.脊髓损伤后的细胞反应和分子变化[J].中华创伤杂志,2005,21(9):717-720. 被引量:1
  • 2原野,赵静,李永民.核因子κB和肿瘤坏死因子α在正常椎间盘及其退行性变组织中的表达[J].中国临床康复,2006,10(28):22-22. 被引量:7
  • 3宋旭东,李志强,朱海燕.P27^(kip1)和Skp2在食管癌中的表达[J].第四军医大学学报,2007,28(1):21-23. 被引量:9
  • 4Winawer SJ.The national polyp study:design,methods,and characteristics of patients with newly diagnosed polyps.The National Polyps Study Workgroup[J].Cancer,1992,70(5 Suppl):1236-1245.
  • 5Fromowitz FB,Viola MV,Chao S,et al.Ras p21 expression in the progression of breast cancar[J].Hum Pathol,1987,18(12):1268-1275.
  • 6Michaselson JS,Leder P.Beta-catentin is a downstream effector of wnt-mediated tumorigensis in the mammary gland[J].Oncogene,2001,20(37):5093-5099.
  • 7Polyak K,Lee MH,Erdjument-Bromage H,et al.Cloning of p27kip1,a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogentic signals[J].Cell,1994,78(1):59-66.
  • 8Schmitz MJ,Hendricks DT,Farley J,et al.p27 and cyclindl abnor malities in uterine papillary serous carcinoma[J].Gynecol Oncol,2000,77(3):439-445.
  • 9Kuo MY,Hsu HY,Kuo SH,et al.Prognostic role of p27kip1 expression in oral squamous cell carcinoma in Taiwan[J].Oroal Oncol,2002,38(2):172-178.
  • 10Thomas GV,Sziget K,Murphy M,et al.Down regulation of p27kip1 is associated with development of colorectal adenocarcinoma metastases[J].Am J Pathol,1998,153(2):681-687.

共引文献19

同被引文献24

引证文献1

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部